Yi Luo
About
Yi Luo is a scholar working on Hematology, Oncology and Immunology.
According to data from OpenAlex, Yi Luo has authored 174 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 99 papers in Hematology, 44 papers in Oncology and 37 papers in Immunology. Recurrent topics in Yi Luo's work include Hematopoietic Stem Cell Transplantation (73 papers), Acute Myeloid Leukemia Research (41 papers) and Acute Lymphoblastic Leukemia research (26 papers). Yi Luo is often cited by papers focused on Hematopoietic Stem Cell Transplantation (73 papers), Acute Myeloid Leukemia Research (41 papers) and Acute Lymphoblastic Leukemia research (26 papers). Yi Luo collaborates with scholars based in China, United States and France. Yi Luo's co-authors include He Huang, Jimin Shi, Yamin Tan, Yanmin Zhao, Xiaoyu Lai, Zhen Cai, Yongxian Hu, Jian Yu, Lizhen Liu and Weiyan Zheng and has published in prestigious journals such as Nucleic Acids Research, Nature Communications and Journal of Clinical Oncology.
In The Last Decade
Yi Luo
151 papers receiving 1.7k citations
Hit Papers
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late) cites · hero ref
| Name | h | Career | Trend | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| Yi Luo China | 21 | 771 | 416 | 385 | 342 | 247 | 174 | 1.7k | ||
| Henrique Bittencourt Canada | 23 | 903 1.2× | 435 1.0× | 322 0.8× | 235 0.7× | 383 1.6× | 90 | 1.6k | ||
| Nobuharu Fujii Japan | 25 | 781 1.0× | 675 1.6× | 786 2.0× | 358 1.0× | 118 0.5× | 154 | 2.0k | ||
| Jihyang Lim South Korea | 19 | 503 0.7× | 244 0.6× | 269 0.7× | 264 0.8× | 254 1.0× | 114 | 1.3k | ||
| C. Darrell Jennings United States | 20 | 707 0.9× | 299 0.7× | 602 1.6× | 450 1.3× | 157 0.6× | 58 | 1.8k | ||
| T. de Witte Netherlands | 23 | 875 1.1× | 394 0.9× | 335 0.9× | 254 0.7× | 228 0.9× | 54 | 1.4k | ||
| Friedrich Stölzel Germany | 22 | 1.0k 1.3× | 409 1.0× | 215 0.6× | 539 1.6× | 241 1.0× | 92 | 1.9k | ||
| Robert M. Dean United States | 26 | 961 1.2× | 916 2.2× | 525 1.4× | 418 1.2× | 270 1.1× | 173 | 2.4k | ||
| Siddhartha Ganguly United States | 21 | 617 0.8× | 784 1.9× | 209 0.5× | 618 1.8× | 99 0.4× | 138 | 1.6k | ||
| Renée M. Y. Barge Netherlands | 23 | 504 0.7× | 343 0.8× | 318 0.8× | 379 1.1× | 130 0.5× | 44 | 1.5k | ||
| Marcel P. Devetten United States | 20 | 704 0.9× | 263 0.6× | 288 0.7× | 433 1.3× | 216 0.9× | 45 | 1.5k |
Countries citing papers authored by Yi Luo
Since
Specialization
Citations
This map shows the geographic impact of Yi Luo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yi Luo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yi Luo more than expected).
Fields of papers citing papers by Yi Luo
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Yi Luo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yi Luo. The network helps show where Yi Luo may publish in the future.
Co-authorship network of co-authors of Yi Luo
This figure shows the co-authorship network connecting the top 25 collaborators of Yi Luo. A scholar is included among the top collaborators of Yi Luo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yi Luo. Yi Luo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Hu, Ximin, Yi Luo, Yiya Zhang, et al.. (2025). CB2R-cAMP-Epac1 pathway orchestrates epithelial–neural–immune interactions in atopic dermatitis. Journal of Allergy and Clinical Immunology. 156(6). 1614–1627.
2.
Shi, Ce, Xiangjun Zeng, Yi Luo, et al.. (2025). Machine learning-based prediction of G-CSF-induced hematopoietic stem cell mobilization outcomes in healthy volunteers. Bone Marrow Transplantation. 60(10). 1316–1324.
3.
Chen, Weihao, Yang Cao, Yi Luo, et al.. (2024). Validation and refinement of the 2022 European LeukaemiaNet genetic risk classification of acute myeloid leukaemia patients receiving allogeneic haematopoietic cell transplantation. Leukemia. 38(12). 2712–2716.
4.
Liu, Yan-Zhao, et al.. (2024). Identification of effective diagnostic genes and immune cell infiltration characteristics in small cell lung cancer by integrating bioinformatics analysis and machine learning algorithms. Saudi Medical Journal. 45(8). 771–782.
5.
Zhu, Panpan, Jimin Shi, Lizhen Liu, et al.. (2024). Graft CD8 T‐cell‐based risk system predicts survival in antithymocyte globulin‐based myeloablative haploidentical peripheral blood stem cell transplantation. Clinical & Translational Immunology. 13(1). e1484–e1484.
6.
Jiang, Bingqian, Yanmin Zhao, Yi Luo, et al.. (2024). Outcomes of Allogeneic Hematopoietic Stem Cell Transplantation in Adult Patients With Acute Myeloid Leukemia Harboring KMT2A Rearrangement and Its Prognostic Factors. Cell Transplantation. 33. 4231283677–4231283677.
7.
Chen, Weihao, Jimin Shi, Yi Luo, et al.. (2024). Risk factors and long-term outcomes for human herpesvirus 6 encephalitis in the early period after allogeneic stem cell transplantation. Bone Marrow Transplantation. 59(10). 1387–1393.
8.
Zhu, Panpan, Xiaoyu Lai, Lizhen Liu, et al.. (2024). Impact of myelofibrosis on patients with myelodysplastic syndromes following allogeneic hematopoietic stem cell transplantation. Journal of Translational Medicine. 22(1). 275–275.
9.
Zhao, Yun, Lu Huang, Dazhong Tang, et al.. (2023). Improvement in coronary microvascular dysfunction evaluated by cardiac magnetic resonance in patients with hypertrophic obstructive cardiomyopathy after transapical beating-heart septal myectomy. Frontiers in Cardiovascular Medicine. 10. 1233004–1233004.
10.
Shi, Jimin, Xiaoyu Lai, Yanmin Zhao, et al.. (2023). Survival and late mortality among patients who survived disease‐free for 2 years after stem cell transplantation. British Journal of Haematology. 202(3). 608–622.
11.
Lai, Xiaoyu, Jimin Shi, Lizhen Liu, et al.. (2023). A novel risk model for predicting early relapse in acute myeloid leukemia patients undergoing allogeneic hematopoietic stem-cell transplantation. Bone Marrow Transplantation. 58(7). 801–810.
12.
Gao, Fei, Jimin Shi, Yi Luo, et al.. (2023). Donor aKIR genes influence the risk of EBV and CMV reactivation after anti‐thymocyte globulin‐based haploidentical hematopoietic stem cell transplantation. HLA. 103(1). e15320–e15320.
13.
Liu, Lizhen, Xinyu Ji, Panpan Zhu, et al.. (2023). Double filtration plasmapheresis combined with rituximab for donor‐specific antibody desensitization in haploidentical haematopoietic stem cell transplantation. British Journal of Haematology. 203(5). 829–839.
14.
Wang, Limengmeng, Yingying Mao, Xiaohui Sun, et al.. (2022). The Global Burden of Leukemia and Its Attributable Factors in 204 Countries and Territories: Findings from the Global Burden of Disease 2019 Study and Projections to 2030. Journal of Oncology. 2022. 1–14.
15.
Liu, Yanru, Panpan Zhu, Jimin Shi, et al.. (2022). Impact of Donor-to-Recipient ABO Mismatch on Outcomes of Antithymocyte Globulin-Based Peripheral Blood Stem Cell-Derived Myeloablative Conditioning Haploidentical Stem Cell Transplantation. Transplantation and Cellular Therapy. 28(6). 331.e1–331.e10.
16.
Feng, Jingjing, Xiaoxiao Xu, Xiaoqing Li, et al.. (2021). IL-17-producing γδT cells ameliorate intestinal acute graft-versus-host disease by recruitment of Gr-1+CD11b+ myeloid-derived suppressor cells. Bone Marrow Transplantation. 56(10). 2389–2399.
17.
Ye, Yishan, Florent Malard, Jimin Shi, et al.. (2021). Comparison of non-first-degree related donors and first-degree related donors in haploidentical HSCT: a multi-centre retrospective analysis. Bone Marrow Transplantation. 56(10). 2567–2574.
18.
Lai, Xiaoyu, Jimin Shi, Yamin Tan, et al.. (2021). Effect of donor characteristics on T cell‐replete haploidentical stem cell transplantation over the last 10 years at a single institution. British Journal of Haematology. 196(5). 1225–1238.
19.
Tan, Yamin, Jimin Shi, Yanmin Zhao, et al.. (2020). Prophylactic modified donor lymphocyte infusion after low-dose ATG-F-based haploidentical HSCT with myeloablative conditioning in high-risk acute leukemia: a matched-pair analysis. Bone Marrow Transplantation. 56(3). 664–672.
20.
Luo, Yi, Haowen Xiao, Xiaoyu Lai, et al.. (2014). T-cell-replete haploidentical HSCT with low-dose anti-T-lymphocyte globulin compared with matched sibling HSCT and unrelated HSCT. Blood. 124(17). 2735–2743.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Henrique Bittencourt Breakdown of academic impact, for papers by Nobuharu Fujii Breakdown of academic impact, for papers by Jihyang Lim Breakdown of academic impact, for papers by C. Darrell Jennings Breakdown of academic impact, for papers by T. de Witte Breakdown of academic impact, for papers by Friedrich Stölzel Breakdown of academic impact, for papers by Robert M. Dean Breakdown of academic impact, for papers by Siddhartha Ganguly Breakdown of academic impact, for papers by Renée M. Y. Barge Breakdown of academic impact, for papers by Marcel P. Devetten